GSK-3882347
- Generic Name
- GSK-3882347
Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years
- First Posted Date
- 2023-03-08
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 27
- Registration Number
- NCT05760261
- Locations
- 🇬🇧
GSK Investigational Site, Cambridge, United Kingdom
Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections
Phase 1
Completed
- Conditions
- Uncomplicated Urinary Tract InfectionsUrinary Tract Infections
- Interventions
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2025-01-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 140
- Registration Number
- NCT05138822
- Locations
- 🇺🇸
GSK Investigational Site, Missouri City, Texas, United States
Safety, Tolerability and Pharmacokinetic Investigation of GSK3882347 in Healthy Participants.
- First Posted Date
- 2020-07-28
- Last Posted Date
- 2023-02-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 61
- Registration Number
- NCT04488770
- Locations
- 🇬🇧
GSK Investigational Site, Cambridge, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath